In the terminal stages of ALS (at 120d in the G93A-hSOD1 ALS mouse), an 11-fold increase in gal-3 was identified in motor neurons compared to age-matched non-transgenic controls (Ferraiuolo et al., 2007), but warrants further analysis to understand its role. Here, LGALS3 is linked to amyotrophic lateral sclerosis.